MyAverix Finance
HK · Healthcare
Yunkang Group Ltd (2325)
Diagnostics & Research
Yunkang Group Ltd (2325) is listed on HK in the Healthcare sector. Industry: Diagnostics & Research. As of 2026-05-21, reported market cap is $439.01M, P/E ratio is 75.00, net margin is 0.5%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 2325
Yunkang Group Ltd (2325) — FAQ
What is Yunkang Group Ltd's market cap?
Yunkang Group Ltd (2325) has a reported market cap of $439.01M (data as of 2026-05-21).
What is 2325's P/E ratio?
The price-to-earnings (P/E) ratio for Yunkang Group Ltd (2325) is 75.00 (data as of 2026-05-21).
Does Yunkang Group Ltd pay a dividend?
Dividend yield is not available in the current snapshot for Yunkang Group Ltd (2325). Check the MyAverix Finance app for the latest dividend data.
What sector is Yunkang Group Ltd in?
Yunkang Group Ltd (2325) is classified in the Healthcare sector (Diagnostics & Research industry).
What exchange is 2325 listed on?
2325 is listed on HK.
What is Yunkang Group Ltd's net margin?
Yunkang Group Ltd (2325) reports a net margin of 0.5% (data as of 2026-05-21).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.